Icosavax Inc. (ICVX)
NASDAQ: ICVX
· Real-Time Price · USD
15.31
-0.14 (-0.91%)
At close: Feb 16, 2024, 10:00 PM
Icosavax Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 63.24M | 155.07M | 49.34M | 58.85M | 64.5M | 108.34M | 261.36M | 279.08M | 291.27M | 110.58M | 121.88M |
Short-Term Investments | 165.97M | 91.86M | 147.25M | 159.46M | 156.89M | 134.46M | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.61M | 2.12M | 2.12M | -14.76M | -15.14M | n/a | n/a | n/a | n/a | 2.27M | 81K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 6.1M | 4.77M | 4.52M | 4.54M | 6.27M | 4.64M | 7.68M | 5.83M | 6.35M | 4.12M | 226K |
Total Current Assets | 235.31M | 251.7M | 202.17M | 223.91M | 228.73M | 248.5M | 270.1M | 286.55M | 300.28M | 115.88M | 125.19M |
Property-Plant & Equipment | 14.38M | 15.2M | 4.39M | 14.76M | 15.14M | 11.18M | 6.55M | 1.08M | 548K | 561K | 143K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 15.99M | 17.33M | 6.5M | 14.76M | 15.14M | 11.18M | 6.55M | 1.08M | 548K | 2.83M | 224K |
Total Assets | 251.3M | 269.03M | 208.67M | 238.68M | 243.88M | 259.68M | 276.64M | 287.63M | 300.82M | 118.71M | 125.41M |
Account Payables | 1.24M | 1.55M | 1.61M | 2.89M | 4.72M | 3.48M | 6.02M | 3.9M | 3.05M | 3.11M | 1.78M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 582K | 2.65M | 1.18M | 3.08M |
Short-Term Debt | 2.19M | 2.17M | 2.15M | 2.14M | 1.59M | 1.06M | 530K | n/a | n/a | n/a | n/a |
Other Current Liabilities | 9.61M | 11.3M | 9.14M | 8.76M | 6.72M | 7.35M | 7.45M | 4.76M | 2.49M | 1.82M | 788K |
Total Current Liabilities | 13.03M | 15.01M | 12.9M | 13.79M | 13.03M | 11.89M | 14M | 9.24M | 8.19M | 6.12M | 5.65M |
Long-Term Debt | 5.89M | 6.27M | 6.64M | 6.66M | 5.09M | 5.24M | 2.96M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 18K | 44K | 69K | 93K | 119K | 144K | 171K | 197K | 151.89M | 151.95M |
Total Long-Term Liabilities | 5.89M | 6.29M | -4.31M | 6.73M | 5.18M | 5.35M | 3.11M | 171K | 197K | 151.89M | 151.95M |
Total Liabilities | 18.92M | 21.3M | 8.59M | 20.52M | 18.21M | 17.25M | 17.11M | 9.41M | 8.38M | 158.01M | 157.6M |
Total Debt | 8.07M | 8.44M | 8.8M | 8.79M | 6.68M | 6.3M | 3.49M | n/a | n/a | n/a | n/a |
Common Stock | 7K | 7K | 6K | 6K | 5K | 5K | 5K | 5K | 5K | 2K | 2K |
Retained Earnings | -258.93M | -236.88M | -210.39M | -185.83M | -162.21M | -140.24M | -117.6M | -94.07M | -75.89M | -41.5M | -32.95M |
Comprehensive Income | -48K | -66K | -63K | -403K | -609K | -275K | -276.64M | n/a | -300.82M | -151.61M | n/a |
Shareholders Equity | 232.38M | 247.72M | 200.08M | 218.16M | 225.66M | 242.43M | 259.54M | 278.22M | 292.44M | -39.3M | -32.19M |
Total Investments | 165.97M | 91.86M | 147.25M | 159.46M | 156.89M | 134.46M | n/a | n/a | n/a | n/a | n/a |